Range Low Price High Price Comment
30 days $13.12 $15.10 Friday, 23rd Feb 2024 CPRX stock ended at $14.04. This is 1.01% more than the trading day before Thursday, 22nd Feb 2024. During the day the stock fluctuated 3.28% from a day low at $13.70 to a day high of $14.15.
90 days $13.00 $17.40
52 weeks $11.09 $18.22

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2024-02-23 $13.91 $14.15 $13.70 $14.04 682 225
2024-02-22 $13.77 $14.02 $13.49 $13.90 1 133 501
2024-02-21 $13.77 $13.90 $13.57 $13.71 739 435
2024-02-20 $14.00 $14.35 $13.66 $13.79 1 303 067
2024-02-16 $13.86 $14.09 $13.71 $14.00 985 088
2024-02-15 $13.56 $13.96 $13.56 $13.89 971 333
2024-02-14 $13.34 $13.53 $13.28 $13.48 908 869
2024-02-13 $13.32 $13.61 $13.13 $13.18 1 474 357
2024-02-12 $13.60 $13.77 $13.52 $13.64 1 114 282
2024-02-09 $13.43 $13.64 $13.30 $13.64 952 646
2024-02-08 $13.32 $13.50 $13.12 $13.37 945 252
2024-02-07 $13.71 $13.71 $13.31 $13.35 846 845
2024-02-06 $13.35 $13.76 $13.23 $13.75 897 775
2024-02-05 $13.45 $13.59 $13.32 $13.39 1 136 703
2024-02-02 $14.43 $14.43 $13.61 $13.62 1 283 482
2024-02-01 $14.51 $14.60 $14.34 $14.43 642 905
2024-01-31 $14.71 $14.84 $14.33 $14.40 1 315 275
2024-01-30 $14.41 $14.83 $14.33 $14.77 1 089 508
2024-01-29 $14.36 $14.54 $14.28 $14.45 1 285 994
2024-01-26 $14.50 $14.58 $14.25 $14.29 942 480
2024-01-25 $14.75 $14.81 $14.40 $14.53 949 451
2024-01-24 $15.06 $15.10 $14.60 $14.60 825 834
2024-01-23 $15.30 $15.35 $14.76 $14.93 890 792
2024-01-22 $14.63 $15.17 $14.48 $15.15 1 322 241
2024-01-19 $14.77 $14.77 $14.49 $14.56 747 356
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT